Skip to content

Effect of combination of remifentanil and dexmetomidine before induction on controlled hypotension during nasal endoscopy

Effect of combination of remifentanil and dexmetomidine before induction on controlled hypotension during nasal endoscopy

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800020056
Enrollment
Unknown
Registered
2018-12-12
Start date
2018-12-05
Completion date
Unknown
Last updated
2018-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic rhinosinusitis

Interventions

Group 1:Pump remifentanil 0.5ug/kg (1min) 0.05ug/kg/min after surgery
Group 2:Pump remifentanil 0.5ug/kg (1min) 0.05ug/kg/min and dexmedetomidine 1ug/kg(10min)+0.5ug/kg/h after surgery
Group 3:Pump remifentanil 0.5ug/kg (1min) 0.05ug/kg/min and dexmedetomidine 1ug/kg(10min)+0.5ug/kg/h before induction

Sponsors

Department of Anesthesiology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed as chronic sinusitis, chronic sinusitis with nasal polyps, chronic sinusitis with nasal septum deviation; 2. Patients voluntarily participated and signed informed consent; 3. Aged between 18 and 60 years; 4. To perform elective endoscopic sinus surgery; 5. ASA I-II.

Exclusion criteria

Exclusion criteria: 1. the patients refused to participate in this study; 2. with myocardial ischemia; 3. with sinus bradycardia, sinus syndrome; 4. with bronchial asthma; 5. with a history of neurological and mental illness, who took monoamine oxidase inhibitors; 6. those who are known to be allergic to remifentanil or dexmetomidine; 7. others

Design outcomes

Primary

MeasureTime frame
MAP;

Countries

China

Contacts

Public ContactPinjie Huang

Department of Anesthesiology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong Province

hpjie@126.com+86 13724090424

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026